Brazil's Top Appeals Court Rules Health Plans Must Cover Facial Feminization Surgery

Brazil’s Superior Court of Justice (STJ) ruled in July that private health insurance plans must cover facial feminization surgery for transgender patients when a doctor determines it’s medically indicated — rejecting an insurer’s argument that the procedures were cosmetic and therefore excluded from coverage.

The case reached the court’s Third Panel after an insurance operator refused to authorize a set of procedures for a beneficiary who had already completed gender-affirming genital surgery through her plan. Her physician had indicated facial feminization work as the next step in her transition: cranial contouring, chondrolaryngoplasty (reduction of the thyroid cartilage, commonly called an Adam’s apple), and reconstructive rhinoplasty. The insurer argued these fell outside its obligations under Brazil’s health plan law, framing them as aesthetic rather than medical.

What the court actually decided

The justices disagreed, and did so on fairly narrow, technical grounds that nonetheless have broad implications. Brazilian health insurance law, specifically Article 10 of Law 9.656/1998, allows insurers to exclude purely cosmetic procedures from coverage. The STJ found that facial feminization surgery, in the context of a documented gender transition, doesn’t qualify as cosmetic under that exclusion — because it isn’t optional, experimental, or aesthetic in the sense the law means. The court pointed to the fact that Brazil’s Federal Council of Medicine already recognizes facial feminization as a legitimate part of the gender-affirmation process, and that the same set of procedures is available through the public Unified Health System (SUS) for patients who qualify.

The panel’s reasoning centered on necessity rather than appearance: the procedures were indicated by the patient’s own physician as clinically necessary to align her body with her gender identity and to protect her psychological well-being, not selected from a menu of appearance-altering options. That distinction — clinical indication versus patient preference — is what put the case on the “must cover” side of the line rather than the “elective” side where insurers have more latitude to refuse.

Why this ruling carries weight beyond one case

Brazil’s private health insurance market covers roughly a quarter of the population, and disputes between patients and insurers over what counts as “medically necessary” gender-affirming care have been a recurring flashpoint, mirroring fights playing out in US courts over the same basic question. Facial feminization surgery in particular has often gotten waved off by insurers worldwide as elective or cosmetic, even though clinical literature and provider organizations like WPATH have for years classified it as a recognized component of transition-related care for patients who need it.

An STJ ruling isn’t automatically binding on every future case the way a Supreme Federal Tribunal decision would be, but decisions from the Third Panel carry significant persuasive weight in Brazil’s lower courts, which handle the bulk of individual insurance disputes. Attorneys who work on gender-affirming care access cases in Brazil said the ruling gives patients a much stronger citation to invoke the next time an insurer tries to deny similar procedures, and makes it harder for operators to treat facial feminization as a bargaining chip in coverage disputes.

Part of a broader — and uneven — pattern in Brazil

The ruling lands in a year that’s been a genuine mixed bag for trans rights in Brazil. In February, the country’s Supreme Court struck down state and municipal laws in Amazonas and Navegantes that had banned gender-neutral language in schools. In June, a judge authorized hormone-blocking treatment for a 13-year-old transgender adolescent. At the same time, Alagoas passed a state law in March barring young people from participating in Pride parades, and Salvador’s mayor signed a municipal measure prohibiting gender identity instruction in city schools — both signs that the backlash politics reshaping trans rights debates elsewhere have a foothold in Brazil too.

Brazil’s Congress is also weighing a broader “Equality Act” that would codify gender-identity protections nationally, including automatic legal gender recognition on identity documents without a medical report requirement. Whether that bill moves this year is an open question. For now, the STJ’s ruling on facial feminization surgery does something narrower but immediate: it closes off one of the more common ways Brazilian insurers have tried to draw an arbitrary line between the parts of transition care they’ll pay for and the parts they won’t.